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RESEARCH ARTICLE
Genome-wide ChIP-seq analysis of human TOP2B occupancy in
MCF7 breast cancer epithelial cells
Catriona M. Manville1,*, Kayleigh Smith1,*, Zbyslaw Sondka1,*, Holly Rance1, Simon Cockell2, Ian G. Cowell1,
Ka Cheong Lee1, Nicholas J. Morris3, Kay Padget4, Graham H. Jackson5 and Caroline A. Austin1,‡
ABSTRACT
We report thewhole genomeChIP seq for human TOP2B fromMCF7
cells. Using three different peak calling methods, regions of binding
were identified in the presence or absence of the nuclear hormone
estradiol, as TOP2B has been reported to play a role in ligand-
induced transcription. TOP2B peaks were found across the whole
genome, 50% of the peaks fell either within a gene or within 5 kb of a
transcription start site. TOP2B peaks coincident with gene promoters
were less frequently associated with epigenetic features marking
active promoters in estradiol treated than in untreated cells.
Significantly enriched transcription factor motifs within the DNA
sequences underlying the peaks were identified. These included
SP1, KLF4, TFAP2A, MYF, REST, CTCF, ESR1 and ESR2. Gene
ontology analysis of genes associated with TOP2B peaks found
neuronal development terms including axonogenesis and axon
guidance were significantly enriched. In the absence of functional
TOP2B there are errors in axon guidance in the zebrafish eye.
Specific heparin sulphate structures are involved in retinal axon
targeting. The glycosaminoglycan biosynthesis–heparin sulphate/
heparin pathway is significantly enriched in the TOP2B gene ontology
analysis, suggesting changes in this pathway in the absence of
TOP2B may cause the axon guidance faults.
KEY WORDS: ChIP seq, TOP2B, Topoisomerase II
INTRODUCTION
The topoisomerase family of nuclear enzymes catalyse the
interconversion of different topological forms of DNA. Two type
II topoisomerase isoforms are present in vertebrate cells, TOP2A
(topoisomerase IIα) and TOP2B (topoisomerase IIβ) (Austin and
Marsh, 1998). The TOP2 catalytic mechanism involves the
simultaneous cleavage of both DNA strands of a double-stranded
DNA segment, transiently leaving the 5′-ends covalently attached
to the dimeric topoisomerase enzyme via 5′-phosophotyrosine
linkages to each monomer. A second DNA duplex can then pass
through the enzyme-bridged DNA gate in a strand passage reaction,
prior to religation of the break. From previous studies using in vitro
DNA cleavage and footprinting analysis it was shown that TOP2
protects a region of 25 (Drosophila TOP2) or 28 (mammalian
TOP2) nucleotides, with the TOP2 DNA cleavage site in the centre
of the protected region (Lee et al., 1989; Thomsen et al., 1990).
Crystal structures of the cleavage and re-joining domains of TOP2A
and TOP2B complexed to nicked oligonucleotide substrates reveal
TOP2:DNA complexes containing symmetrical dimers of TOP2,
confirming previous biophysical studies (Wendorff et al., 2012; Wu
et al., 2011). TOP2B displays an apparent dissociation constant for
linear DNA of 130 nM assessed by electrophoretic mobility shift
analysis (EMSA) (West and Austin, 1999). By comparison, the
transcription factor SP1 displayed an EMSA-derived KD of 0.4 nM
for a consensus DNA binding site (Letovsky and Dynan, 1989).
Beyond these in vitro studies, the recruitment and binding of human
TOP2 to specific loci in the context of chromatin is poorly
understood.
TOP2A is required for chromatin condensation and chromosome
segregation and is essential in eukaryotic cells (Akimitsu et al.,
2003). By contrast, TOP2B is not essential for human or mouse cells
in culture (Dereuddre et al., 1997), but Top2b−/− mice are non-
viable. Top2b null embryos exhibit no gross abnormalities in the
morphology of major organs during development, but exhibit a
defect in neural development where motor axons fail to form
contacts with skeletal muscles and sensory axons do not enter the
spinal cord, although neurogenesis appears to be normal. Failure to
innervate the diaphragm, resulting in an inability to breath is thought
to be the cause of perinatal lethality (Yang et al., 2000).
Furthermore, cultured neurons lacking Top2b produced shorter
neurites than wild type neurons, suggesting Top2b is involved in the
process of neurite outgrowth (Nur-E-Kamal et al., 2007). The nature
of the defects observed in Top2b−/− cells suggests a possible role for
Top2b in gene expression programs required for late neural
development, and expression analysis in murine brain revealed
that about a third of developmentally regulated genes exhibit altered
expression (mostly exhibiting reduced expression) in Top2b−/−
mice compared to wild-type siblings. Top2b was shown to be
present in the 5′ and upstream regions of a number of Top2b-
sensitive genes, suggesting a direct role of Top2b in transcription of
these genes, but not genes that were insensitive to Top2b (Lyu et al.,
2006; Tiwari et al., 2012). The requirement for Top2b during neural
development is consistent with a previous finding that Top2b
mRNA levels significantly increase in murine neonatal brain
(Capranico et al., 1992). It appears that Top2b becomes crucial as
neural cells enter the postmitotic stage, when Top2a is down
regulated (Tiwari et al., 2012). Interestingly, Top2b represses the
neurotrophin gene (Ngfr p75) and up-regulation of this gene has
been implicated in cell death of Top2b−/− neurons. A cre-lox
Top2b−/− murine model demonstrated that neurons lacking Top2b
had defective positioning in the cerebral cortex (Lyu and Wang,
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by studies in rat. RNA in situ analyses in rat brain at P10 (Tsutsui
et al., 1993) shows high level expression in the cerebellum and
Top2b has been shown to be involved in granule cell differentiation
(Tsutsui et al., 2001). Top2b DNA complexes were isolated from rat
cerebellar granule cells by chromatin immunoprecipitation (ChIP)
followed by microarray analysis (ChIP on chip) demonstrating that
Top2b is associated with genes essential for neuronal maturation
and that Top2b-dependent genes encoded long transcripts (Lyu
et al., 2006; King et al., 2013; Sano et al., 2008).
In zebrafish, top2a is maternally encoded and is essential for
development (Amsterdam et al., 2004; Dovey et al., 2009; Sapetto-
Rebow et al., 2011). In contrast, top2b is not maternally encoded
and expression commences after the mid blastula transition
becoming widely expressed in the developing embryo. Consistent
with a conserved role for top2b in neural development, the blind
notorious (noto) mutant isolated in an ENU forward genetic screen
is characterised by neurite targeting defects in retinal ganglion cell
axons and dendrites and is caused by a mutation in top2b (Nevin
et al., 2011).
TOP2B expression during human development has been
analysed by in situ analysis (Zandvliet et al., 1996). Human
TOP2B protein directly interacts with a number of proteins
including CD3ε UBC9, TOPBP1, p53, pRB, SNF2H, HDAC1
and HDAC2 (Cowell et al., 2000; Johnson et al., 2001; LeRoy et al.,
2000; Mao et al., 2000; Nakano et al., 1996; Tsai et al., 2000; Xiao
and Goodrich, 2005; Yamane et al., 1997; Yuwen et al., 1997)
several of which are involved in transcriptional regulation.
Inhibition of HDACs by TSA redistributes TOP2B from
heterochromatin to euchromatin in mouse epithelial cells (Cowell
et al., 2011). TOP2B is also found associated with several
complexes involved in the regulation of transcriptional initiation.
It is a component of the Groucho/TLE1 co-repressor complex,
alongside a PARP sensor which triggers a switch from neurogenic
gene repression to neurogenic activation mediated by CaMKinase
IIδ (Ju et al., 2004). TLE1 also promotes neuronal survival of post
mitotic neurons, in combination with FoxG1 (Dastidar et al., 2012),
consistent with the suggestion that murine Top2b is involved in
preventing the premature death of post mitotic neurons (Tiwari et al.,
2012).
TOP2B is involved in ligand mediated transcription in response
to estradiol, androgen, retinoic acid, thyroid hormone or TPA
(Haffner et al., 2010; Ju et al., 2006), and in response to insulin in
liver cells in the induction of fatty acid synthase (FAS) expression
(Wong et al., 2009). In each of these examples, it has been
demonstrated that the inducing agent (steroid hormone ligand or
insulin) leads to the recruitment of TOP2B along with DNA-PK and
PARP to the 5′ region of the gene in question and the formation of a
promoter DNA double-strand break that is presumed to be induced
by TOP2B. In the case of the FAS gene it has been suggested that the
DSB serves to activate DNA-PK to then modulate one or more
further promoter-bound factor(s) via phosphorylation. It is likely
that in at least the case of FAS, TOP2B interacts with DNA-PK since
in the absence of DNA-PK TOP2B is not recruited to chromatin
(Wong et al., 2009). Ligand-dependent chromatin recruitment of
TOP2B with 17β-estradiol was confirmed in MCF7 cells (Ju et al.,
2006; Cowell et al., 2012) and RA induced recruitment of TOPB to
the 5′-region of the RARB, was reported byMcNamara et al. (2008),
who showed that TOP2B-mediated repression of RA-induced genes
could lead to RA resistance in APL cell lines. Thus, TOP2B is
recruited to various promoter regions in response to nuclear
hormones and insulin and is required for the completion of neural
development. TOP2B is also reported to be involved in
transcriptional elongation (King et al., 2013) especially of long
genes. Topoisomerases also have a role in determining chromatin
supercoiling over larger distances, in the form of supercoiling
domains which are defined as alternating domains of relative over-
or under-winding of DNA (Naughton et al., 2013).
To further study the recruitment ofTOP2B to chromatin in response
to a signal such as steroid hormone ligand binding, we set out to
determineTOP2Bgenomic distribution and its changesuponestradiol
stimulation usingChIP-seq inMCF7cells. Since the studies described
above (Ju et al., 2006; Cowell et al., 2012; Perillo et al., 2008) had
demonstrated localised recruitment of TOP2B to specific chromatin
regions of genes analysed by ChIP analysis, we hypothesised that
TOP2B chromatin distribution would appear as peaks of increased
binding at the resolution achieved by ChIP-seq. Therefore, we
employed three peak-calling methods (including manual inspection)
to identify regions of localised TOP2B occupancy. In control and
estradiol-treated cells 2872 and 3265 peaks were identified by two or
more of the peak finding methods employed. Surprisingly, TOP2B
peaks were less frequently coincident with transcription-associated
features after estradiol treatment, suggesting a role of TOP2B in
repression of transcription. Gene ontology enrichment analysis of
genes associated with TOP2B peaks highlighted a number of
processes in neuronal development including axonogenesis and
axon guidance.
RESULTS
Genome wide identification of TOP2B sites of occupancy in
MCF7
ChIP-seq was carried out to determine the sites of occupancy of
TOP2B in human MCF7 cells. Since previous work had suggested
a role for TOP2B in the transcriptional regulation of specific genes
in response to estradiol (Ju et al., 2006; Perillo et al., 2008), we
carried out chromatin immunoprecipitation (ChIP) from cells
treated with 17β-estradiol (E2, 10 nM, 30 min), and untreated cells.
Recovered DNA was subject to single-end sequencing on an
Illumina Genome Analyser II. Sixty seven million TOP2B ChIP-
Seq reads were aligned to the human reference genome. As TOP2B
has a lower affinity for DNA than sequence specific transcription
factors for which ChIP was previously used, TOP2B lacks their
high DNA sequence specificity it was unclear how best to analyse
the sites of binding of TOP2B. Therefore we initially carried out a
visual manual inspection of aligned sequence reads using Genome
Studio software (2008.1 Framework). Employing input as controls
revealed the presence of peaks in the distribution of aligned
TOP2B reads. Two example peaks are shown in Fig. 1A one with
estradiol on HS2ST1 and one without estradiol on PKM.
Subsequently, two computational peak finding methods were
utilised, the Model-based Analysis of ChIP-Seq (MACS) peak
calling algorithm (Zhang et al., 2008) and Site Identification from
Short Sequence Reads (SISSRs) (Jothi et al., 2008). For MACs and
SISSRs sequence tags derived from input chromatin were used to
control for amplified regions in MCF-7 cells. Thus, three peak sets
were produced (manual, MACs and SISSRs) for E2-treated MCF7
cells and three peak sets for untreated cells. These TOP2B peaks
indicate occupancy sites for TOP2B in the genome and merging all
three peak sets gave 27,341 and 30,908 peaks, (merged peak sets)
from untreated and E2-treated MCF7 cells respectively. The most
stringent peaks were defined as those identified by all three
methods. These numbered 203 from untreated cells and 360 from
E2-treated cells. This subset included approximately 1% of the
peaks, whilst over 9% of the peaks were identified by two
methods. Thus more than 10% of the peaks were found by at least
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two peak calling methods; 2872 and 3265 for untreated and E2-
treated cells respectively (Fig. 1B). The high confidence sets of
TOP2B peaks called by at least two methods were used for further
analysis unless otherwise indicated and we refer to these sets as
TOP2B2 peak sets from hereon in. Twenty six peaks were
validated by ChIP-qPCR and the data obtained for these in
untreated and E2-treated cells was calculated as a percentage of
input, the ratio of the signals for untreated and estradiol treated
cells is shown in Fig. 1C.
Genomic location of TOP2B peaks
The distribution of the merged sets of TOP2B peaks identified by
manual, MACs and SISSRs (27,341 and 30,908) across the genome
from untreated and E2-treated cells are shown in a circle diagram in
Fig. 2A. TOP2B peaks were observed across the whole genome,
with a slightly higher density on chromosomes 6 and 7 (Fig. 2A).
Apart from chromosomes 6 and 7 the number of peaks on a
chromosome is proportional to chromosome length under both
treatments (Fig. 2B). Interestingly some chromatin regions become
Fig. 1. TOP2B ChIP-seq peak identification. Peaks of TOP2B occupancy were identified by manual inspection of aligned sequence reads and by MACS and
SISSRS. (A) Example TOP2B peaks identified by manual analysis. Top forward (blue) and reverse (amber) 36 base sequence reads corresponding to peaks
identified in the HS2ST1 and PKM genes. Tracks are shown for Input and TOP2B ChIP derived from untreated (−E2) and estradiol-treated (+E2) cells. Bottom,
larger genomic region centred on the peak showing average base density/coverage of reads, a 20 kb scale bar is shown. (B) Venn diagram representing
intersects in sets of peaks called by the three analysis methods for untreated and E2-treated cells respectively. (C) Quantitative TOP2BChIP PCR validation of 26
examples of peak regions identified by two or more peak calling methods the ratios of the +E2/−E2% input values are shown (light blue bars). Data for the E2-
responsive pS2 promoter are also shown (dark blue bars). All ChIP experiments included an AcH3 GAPDH ChIP, the average +E/−E ratio for this is also shown
(black bar). Data is presented as mean±s.e.m.
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more- or less peak-rich upon the treatment suggesting that TOP2B
occupancy on the chromatin is dynamic, to illustrate this the peak
distribution with and without estradiol on chromosome 17 is shown
(Fig. 2C). The location of the TOP2B peaks relative to genes was
determined globally for the combined set of peaks obtained by any
calling method (merged peak set), and for the TOP2B2 peak sets
(those peaks called by at least two methods) (Fig. 2D). TOP2B
peaks were assigned one of the following categories – peak on a
gene, (intragenic, TSS to the end of the mRNA transcript); peak in a
promoter region, (5 kb upstream of a TSS); peak at the 3′ end of
a gene, (5 kb downstream of the gene); or within 100 kb of the 5′
end of a gene (100 kb upstream) or within 100 kb of the 3′ end of a
gene (100 kb downstream) or more than 100 kb from a gene (gene
desert). Analysis of both peak sets yielded very similar percentages
of peaks in each category in the presence or absence of ligand,
(Fig. 2D). Approximately 75% of both data sets arewithin 100 kb of
a gene. 100 kb was used as ERα has been shown to influence gene
expression up to 100 kb (Lin et al., 2007; Carroll et al., 2006). In
both treatments 48% of the TOP2B peaks were found on genes and
2% within 5 kb upstream. Thus, half of the TOP2B peaks are found
Fig. 2. Global distribution of TOP2 peaks. (A) Circle plot displaying TOP2B peak density for all chromosomes. Outer circle, chromosome G-banding ideogram;
middle circle, TOP2B peak density for untreated cells; inner circle, TOP2B peak density for E2-treated cells. The colours in A come from an ‘R color brewer’,
an eleven division reversed spectral palette was used, from blue to red. Blue is the lowest and red the highest. Peak density plots and the data in (B) are derived
from the ‘merged peak sets’ containing all of the peaks identified by each of the peak calling methods. (B) Correlation of peak number with chromosome length.
(C) Distribution of TOP2B peak density across a representative chromosome (Chr17) for E2-treated and untreated cells with gene density (horizontal bar).
(D) Global distribution of TOP2B peaks in relation to genes for the ‘merged peak sets’ (see above) and the TOP2B
2
sets, corresponding to peaks called by any of
the peak calling methods or by two methods, respectively.
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on a gene or within 5 kb of a TSS. This is comparable to the
percentage of ERα binding sites found on a gene or within 5 kb of
the TSS, average 48% (Lin et al., 2007; Joseph et al., 2010).
Next we identified TOP2B peaks that coincided with
transcriptional markers. The location of TOP2B2 peaks were
analysed for coincidence with histone markers of transcriptional
activation (H3K4me1, H3K4me3, H3K9ac, and H3K14ac) or
transcriptional repression (H3K9me3 and H3K27me3) (Joseph
et al., 2010), with RNA pol II ChIP, open chromatin (FAIRE) and
with CpG islands (Fig. 3). Estradiol treatment decreased the
proportion of TOP2B peaks associated with transcriptional
activation markers; the largest decrease (4.7 fold) was observed at
the H3K4me3 sites which are associated with active promoters.
In the absence of estradiol ∼2% of the TOP2B2 peaks were
coincident with H3K4me3 marks and this reduced with estradiol
treatment. In contrast following estradiol treatment the proportion of
TOP2B peaks at H3K27me3 sites associated with transcriptional
repression increased slightly (Fig. 3A). Coincidence between CpG
islands and the TOP2B peaks was determined by comparison to the
CpG island track in UCSC. In the untreated cell data set 4.63% of
the TOP2B peaks coincided with a CpG island (133 peaks).
Following exposure to estradiol for 30 min only 0.74% of the
TOP2B peaks coincided with a CpG island (24 peaks) (Fig. 3B).
There are estimated to be 45,000 CpG islands in the human genome
(Antequera and Bird, 1993), roughly 1.5% of the genome is made
up of CpG islands, therefore CpG islands are over represented
(4.63%) in the TOP2B peak data set from untreated MCF7 cells and
underrepresented (0.74%) in the TOP2B peak data set from MCF7
cells treated with estradiol. E2 treatment also resulted in reduced
association of TOP2B peaks with RNA pol II. However, unlike the
reduced association with transcription-associated histone
modification features, E2-treatment did not change the proportion
of TOP2B peaks associated with open chromatin, as determined by
FAIRE (Fig. 3B; Fig. S2).
In the converse analysis to determinewhich histonemodifications
co-localise with TOP2B peaks, estradiol substantially reduced the
percentage of each of the transcription-associated epigenetic
features (except FAIRE) and CpG islands associated with TOP2B
peaks (Fig. S2). For example ∼0.2% of the H3K4Me3 peaks co
localised with TOP2B2 peaks in the absence of estradiol and this
reduced 4.1 fold with estradiol. Fig. 3C shows the distribution of
TOP2B2 peaks relative to the nearest TSS. Upon treatment with
estradiol there is a reduction in the number of TOP2B peaks near
transcription start sites. In the TOP2B2 set 4.84% (139/2872) of
peaks in the untreated data set are within 1 kb either side of a TSS
compared to 2.97% (97/3265) of the peaks in the E2-treated data set
(Fig. 3C). Thus, the distribution of TOP2B peaks changes in
response to estradiol, with a decreased proportion of TOP2B peaks
coincident with H3K4me3 (Fig. 3A), CpG islands and RNA pol II
sites (Fig 3B) and fewer TOP2B peaks near TSSs in the presence of
E2 (Fig. 3C).
Gene ontology for genes associated with TOP2B peaks
The TOP2B2 peaks were intersected with the UCSC known genes
database to identify the genes bearing TOP2B peaks (Table S2).
Gene ontology enrichment analysis was carried out using GOstats
Bioconductor package, using a hypergeometric test (Falcon and
Gentleman, 2007) to identify cellular components, biological
processes and molecular functions that are carried out by the
proteins encoded by the genes. These are displayed as heatmaps in
Fig. S3, where an FDR cut off of <0.01 was used.
The most enriched cellular components included neuron part,
neuron projection, cell projection and dendrite, consistent with the
known association of TOP2B with neuronal development reported
in mouse, rat and zebrafish development (Yang et al., 2000; Nur-E-
Kamal et al., 2007; Tiwari et al., 2012; Capranico et al., 1992; Lyu
and Wang, 2003; King et al., 2013; Sano et al., 2008; Nevin et al.,
2011).
Biological processes involved in neuronal development were also
significantly over-represented in both the untreated and E2 treated
data sets. Terms over-represented in the untreated data set but not in
the treated set included protein auto-phosphorylation and cellular
response to stimulus, those overrepresented only in the E2 treated
dataset included glutamate receptor signalling and negative
regulation of signal transduction.
Fig. 3. Estradiol treatment reduces the frequency of TOP2B occupancy at
sites associated with transcriptional activation markers. (A) A smaller
proportion of TOP2 peaks coincide with epigenetic markers of transcriptional
activation in E2-treated than in untreated MC7 cells. (B) Estradiol treatment
leads to a pronounced reduction in TOP2B peaks that coincide with CpG
islands and sites of RNA pol II occupancy but not with accessible chromatin
regions (FAIRE). (C) Effect of estradiol treatment on global distribution of
distances of TOP2B peaks from transcription start sites. Data represented in
A-C were derived from the TOP2B
2
sets. Genomic locations enriched for the
histone modifications and other features shown in control or estradiol treated
(10 nM, 3 h) cells were obtained from Gene Expression Omnibus, as detailed
in the legend to Fig. S1. In A and B histone modification and RNA pol II Chip
and FAIRE data correspond to untreated and estradiol treated cells as
indicated below the histograms. TOP2B ChIP without estradiol is shown in
grey, TOP2BChIPwith estradiol is shown in black. The data it was compared to
was determined in the presence or absence of estradiol as indicated by + or −.
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The enriched molecular functions included signalling processes.
Protein tyrosine kinase activity in the absence of estradiol but not its
presence. Protein binding, calmodulin binding, ion channel activity,
GTPase regulator activity and glutamate receptor activity were most
significantly enriched in the E2-treated set, consistent with the
previously reported functions of estradiol (Hedges et al., 2012;
Meitzen and Mermelstein, 2011).
KEGG pathways significantly enriched for genes associated
with TOP2B peaks
When the strongest TOP2B peaks, those called by all three
peak finding methods were analysed, the KEGG pathway
glycosaminoglycan biosynthesis–heparan sulphate/heparin pathway
was significantly enriched (FDR0.001169266). Heparan sulphate is a
long unbranched polysaccharide which is covalently attached to
various proteins (heparin sulphate proteoglycans) on the cell surface
and in the extracellular matrix. A TOP2B peak was observed by all
three peak callingmethods on the gene encoding heparan sulfate 2-O-
sulfotransferase 1 (HS2ST1), shown in Fig. 1A. HS2ST is an enzyme
2-O-suphurotransferase that transfers sulphate to the 2 position of the
iduronic acid residue of heparan. Specific combinations of 2-O- and
6-O- sulphate groups on heparin sulphate are required for retino-tectal
axon targeting (Irie et al., 2002). In TOP2B2 set, further genes
involved in this pathway appear in the peak list including HS3ST5,
HS6ST2, HS6ST3, NDST3 and EXT2.
A number of KEGG pathways were significantly enriched with
the TOP2B2 sets. Axon guidance is significantly enriched in both
E2-treated and untreated cells (FDRs 1.110957e-03 and 7.741285e-
05). At least 20 genes in the KEGG pathway for axon guidance have
TOP2B peaks associated with them, these include the netrins,
NTNG1 and NTNG2, and the netrin receptor UNC-5; ephrin
receptors, EPHA and EPHB, and the membrane bound tyrosine
kinase FYN; SLIT3 and its receptor ROBO1 (roundabout axon
guidance receptor homolog 1); SEMA3A, SEMA3B and their
co-receptor proteins PLXNs and MET. The intracellular effectors
include GTPases and their associated proteins and kinases. These
include three Rho GTPase regulating proteins ARHGAP13
(SRGAP), ARHGAP26 (FAK), and ARHGEF27 (NGEF), also
RHOD, a RhoGTPase andROCK, a Rho associated protein that acts
as a downstream effector of Rho. The kinases included two serine-
threonine kinases, PAK that links RHOGTPases to the cytoskeleton
and nuclear signalling; and GSK3B, a glycogen synthase kinase
subfamily member. Tyrosine kinases included FYN, a membrane
bound non-receptor protein tyrosine kinase and FRK, a nuclear
tyrosine kinase that negatively regulates proliferation. Other genes
involved in axon guidance with TOP2B peaks are AGAP3, GNA1,
NCK2, CALN and ABLIM1. Enrichment for the KEGG axon
guidance pathway is consistent with TOP2B’s previously reported
role in axon guidance (Yang et al., 2000; Nur-E-Kamal et al., 2007;
Lyu and Wang, 2003; Nevin et al., 2011; Heng et al., 2012).
Three other KEGG pathways are significant in the TOP2B2 set
from untreated cells, focal adhesion (1.300159e-04), glioma
(9.174241e-03), and the ErbB signaling pathway (9.770330e-03).
A number of signalling proteins are enriched in these three
pathways, PKC, PI3K and SHC. PAK is present in focal adhesion
and ERBB signalling as well as in axon guidance.
In the presence of estradiol, in addition to axon guidance,
calcium signalling and three cardiomyopathy pathways are
significantly enriched. Calcium signalling pathway (5.857564e-
04), arrhythmogenic right ventricular cardiomyopathy (ARVC)
(6.770581e-06), dilated cardiomyopathy (4.601454e-04) and
hypertrophic cardiomyopathy (HCM) (2.018838e-03). The three
cardiomyopathies share a number of components associated with
TOP2B2 peaks; these include dystrophin (DMD), integrins, and the
sarcoglycan complex. Several calcium ion channels involved in
cardiomyopathies are associated with TOP2B peaks including the
voltage-dependent calcium channel CACNA1C, the sarcoplasmic
reticulum calcium release channel RYR1, and the Na+/Ca+
exchanger and calcium anti-porter SLC8A1. The latter is also
present in the calcium signalling pathway.
Overlap between genes associated with TOP2B peaks and
genes implicated in autism and schizophrenia
The role of TOP2B in neural development suggests it may be
involved in neurodevelopmental disorders such as autism and
schizophrenia. Genes associated with TOP2B peaks and genes on or
near loci implicated in autism or schizophrenia (Basu et al., 2009;
De Rubeis et al., 2014; Schizophrenia Working Group of the
Psychiatric Genomics Consortium, 2014), have been compared, see
Venn diagram in Fig. 4, the genes are listed in Table S2. TOP2B2
peaks from untreated cells are associated with three genes (CNTN4,
IMMP2L and SATB2) implicated in both autism and schizophrenia
whilst TOP2B2 peaks from E2-treated cells are associated with five
genes (CNTN4, IMMP2L, EPC, SMG6 and CACNA1C). CACNA1C
is a calcium channel with strong links to autism and schizophrenia
(Bhat et al., 2012; Giusti-Rodríguez and Sullivan, 2013), it is also
implicated in cardiomyopathies. CNTN4 and IMMP2L come up in
both peak sets. Contactin CNTN4 is a glycosylphosphatidylinositol-
anchored membrane protein that functions in neuronal plasticity and
IMMP2L is an inner mitochondrial membrane peptidase-like
mitochondrial protein involved in processing the signal peptide
sequences to direct mitochondrial proteins to the mitochondria.
IMMP2L has also been implicated in Tourette’s syndrome (Bertelsen
et al., 2014; Gimelli et al., 2014).
Sequence motifs within the TOP2B peaks
To determine whether TOP2B co localises with site specific
transcription factors, sequence motifs from the JASPAR database of
transcription factor binding profiles (Mathelier et al., 2013) were
identified in the sequences within the TOP2B2 peak set. ESR1 and
ESR2 motifs were present and significantly enriched compared to
random. Twenty three mammalian transcription factor binding
motifs were enriched in the TOP2B2 untreated peak set and these
were associated with eighteen transcription factors. Their levels of
enrichment are shown as a heat map in Fig. 5 and the motifs in
Fig. S4. Eighteen motifs were enriched in TOP2B2 E2-treated peak
set and these motifs were associated with fifteen transcription
factors. Motifs for the following five transcription factors were only
significantly enriched in the absence of estradiol, SP1, KLF4,
Fig. 4. A subset of TOP2B peaks coincidewith autism and schizophrenia-
associated genes. The gene lists for this Venn diagram are shown in
Table S2.
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ERG1, PLAG1, and ZFX, whilst motifs for MZF1 and
TAL1-GATA were only significantly enriched in the presence of
estradiol. The remaining transcription factor binding motifs were
enriched in the presence or absence of estradiol. These factors were
TFAP2A, MYF, REST, CTCF, TCFCP2l1, PAX5, INSM1, MAFB,
ESR1, ESR2, EWSRI-FLI1, AP1 and PPARG. It is possible that
factors that only reached significance in the absence of estradiol
SP1, KLF4, EGR1, PLAG1 and ZFX, or in the presence of estradiol
MZF1 and TAL1:GATA1 may be responsible for the differential
transcription in the presence and absence of estradiol.
Peaks with enriched transcription factor sequence motifs were
plotted against distance from a transcription start site, up to 20 kb
either side of a TSS. Fig. 6 shows plots for peaks bearing
TFAP2A, SP1, KLF4, REST and CTCF motifs, further peaks with
enriched transcription factor motifs are shown in Fig. S5. In most
cases they display a trend to occur in the proximity of a TSS in the
untreated cell set (shown in green), with a higher preference for a
downstream rather than an upstream localisation (Fig. 6; Fig. S5).
Peaks within 500 bases of a transcription start site were
analysed further, 108 peaks were within 500 bases of a TSS in
the untreated set and 57 in the E2-treated set. Of these peaks 100
in the untreated set and 45 in the E2-treated set spanned at least
one of the enriched transcription factor motifs. These genes are
plotted versus enriched transcription factors in heat maps and are
shown in Fig. S6. The shaded blocks in the heat map show that
some genes have binding sites for several of the enriched
transcription factors. Transcription occurs in transcription
factories and it has been suggested that these factories may
come in different flavours depending upon which transcription
factors are present (Papantonis and Cook, 2013).
Three gene promoters on PKM, RALGAPA2 and RHOD have
TOP2B peaks with enriched transcription factor motifs are shown
schematically in Fig. 7. These three TOP2B peaks also overlap ChIP
seq signals for ERα andRNApol II and are onCpG islands. The peak
on the promoter of PKM (pyruvate kinase, muscle) in the absence of
estradiol is shown in Fig. 1. The TOP2B peak on the PKM promoter
is coincident with a ChIP seq peak for ERα binding and an RNA pol
II ChIP seq peak inMCF7 cells in the absence of estradiol, all three of
these ChIP binding areas are within a CpG island. Twelve of the 23
enriched transcription factormotifs are foundwithin the TOP2B peak
sequence. Five of these motifs are occupied in ENCODE
transcription factor ChIP seq analyses; ESR1.1, ESR1.2, PAX5,
REST, and two SP1.2 sites.PKM gene expression is activated by SP1
in response to insulin (Yamada and Noguchi, 1999; Yamada et al.,
2000). In MCF7 cells PKM is highly expressed in the absence of
estradiol, and it is regulated by estradiol, expression is reduced
by∼50% 40 min after exposure to estradiol (Barrett et al., 2013; Hah
et al., 2011) (GEO accession number 27463).
The TOP2B peak on the RALGAPA2 (Ral GTPase activating
protein, alpha subunit 2) promoter also overlaps with a CpG island,
ERα and RNA pol II ChIP seq peaks. The TOP2B peak on
RALGAPA2 has 14 of the enriched transcription factor motifs within
its sequence, four of these are occupied in encode data ESR1.1 and
ESR1.2 and two SP1.2 sites. RALGAPA2 is a substrate for insulin
Fig. 5. Relative enrichment of
transcription factor binding motifs
associated with TOP2B peaks in
untreated and E2-treated cells.
A negative logarithm of the FDR
corrected P-value for the motif
enrichment. Motifs that are not
significantly enriched are blue, colour
change from yellow to red depicts the
increase in significance of
enrichment.
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activated protein kinase AKT and has similarities to the tuberous
sclerosis complex (Gridley et al., 2005) RALGAPA2 is expressed in
MCF7 cells in the absence of estradiol and is regulated by estradiol,
expression is increased >3 fold at 40 min (Hah et al., 2011) (GEO
accession number 27463).
The TOP2B peak on the RHOD promoter also overlaps with a
CpG island, ERα and RNA pol II ChIP seq peaks. The sequence
bound by TOP2B on the RHOD promoter contains fifteen motifs for
enriched transcription factors. The CTCF site is occupied in encode
data. RHOD is one of the genes in the KEGG axon guidance
pathway. RHOD is expressed in MCF7 cells in the absence of
estradiol and is regulated by estradiol, expression increased >4 fold
at 40 min (Hah et al., 2011) (GEO accession number 27463).
DISCUSSION
It is well established that topoisomerases are part of the overall
machinery required for efficient transcription, regulating negative
superhelical torsion upstream and positive torsion ahead of an
elongating polymerase, as outlined in the twin domain model (Liu
and Wang, 1987; Brill et al., 1987; Egyházi and Durban, 1987;
Schultz et al., 1992; Mondal and Parvin, 2001; Mondal et al., 2003;
Salceda et al., 2006; French et al., 2011; Joshi et al., 2012; Kouzine
et al., 2013, 2014). Transcription and topoisomerase activity also
appear to work in concert to generate large-scale genomic
topological domains (Naughton et al., 2013). More recently,
evidence has come to light suggesting that TOP2B has a role in
regulating transcription of particular sets of genes. Specifically,
Top2b is required for normal neural development (Yang et al., 2000;
Nur-E-Kamal et al., 2007; Lyu et al., 2006; Tiwari et al., 2012) and
TOP2B has been demonstrated to be recruited to certain hormone
responsive promoters upon ligand treatment (Haffner et al., 2010; Ju
et al., 2006; Wong et al., 2009; Perillo et al., 2008). TOP2B
negatively regulates the expression of RARα following exposure
to retinoic acid (McNamara et al., 2008) and was isolated as a
component of the Groucho/TLE repressor complex, along with
PARP1 (Ju et al., 2004). The extracellular ligands appear to trigger a
molecular switch/change of chromatin state via TOP2B. TOP2B is a
component of multi protein complexes that mediates ligand induced
transcriptional responses. PARP1 and DNA-PK are often present in
these complexes. The involvement of TOP2B in both transcriptional
activation and repression is also supported by mouse brain
development studies, where both increases and decreases in
transcription of developmentally regulated genes where found in
the late stages of neuronal differentiation in the absence of Top2b
(Lyu et al., 2006; Tiwari et al., 2012). Thus, for certain genes
at least, TOP2B appears to be required for the full range of
transcriptional response to ligand-induced transcriptional or
differentiation-associated stimuli.
To determine whether TOP2 recruitment is a common feature of
estradiol-regulated genes we carried out ChIP-SEQ with anti-
TOP2B antibodies in human MCF7 cells before and after estradiol
treatment (10 nM) for 30 min to visualise the distribution of TOP2B
in the human genome (Ju et al., 2006; Perillo et al., 2008). Peaks of
binding were identified using three peak calling methods, manual,
MACS and SISSRS methods, peak sets identified by at least two
methods (TOP2B2) were selected for further analysis. The
distribution of TOP2B peaks is shown in Fig. 2, TOP2B peaks
are distributed throughout the genome and their location is dynamic,
as can be seen in Fig. 2C. Two percent of the TOP2B2 peaks fall
within 5 kb upstream of an annotated TSS and 48% fall within
genes is shown in Fig. 2D. Peaks were also analysed for their
coincidence with transcriptional markers (Fig. 3; Fig. S2). Two
percent of the TOP2B2 peak set coincided with H3K4Me3 marks in
untreated cells and this reduced >4 fold in estradiol treated cells,
consistent with reduced TOP2B occupancy at active promoters and
CpG islands following estradiol treatment (Fig. 3; Fig. S2). In this
first whole genome TOP2B analysis, we show that peaks of
occupancy are distributed across the whole genome, and are not
located specifically in promoter regions.
Published GroSEQ data for MCF7 cells treated with 100 nM
estradiol for 10, 40 and 160 min was utilised to determine which
genes are expressed in these cells and which change in response to
estradiol (Hah et al., 2011). Intersects between these gene sets and
TOP2B peaks has been used to determine which genes are
expressed in MCF7 and which ones are regulated by estradiol in
MCF7, this data is shown for the TOP2B2 data sets in Table S2.
Twenty one percent of the non-expressed genes were associated
with TOP2B peaks whilst 32% of expressed genes were associated
with TOP2B peaks. So expressed genes were more frequently
associated with TOP2B peaks than non-expressed genes (32% and
21% respectively) (Table S3).When expressed genes were divided
into those that changed in response to estradiol and those that did
not, 30% of the genes that did not change in response to estradiol
had TOP2B peaks and 34% of those that changed had TOP2B
Fig. 6. Distribution in relation to TSSs of transcription factor motifs found within TOP2B peaks in untreated (green) and E2-treated cells (red). The
number of peaks co-localized with enriched transcription factor motifs depending on their distance from a TSS in untreated cells (green) or E2-treated cells (red).
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peaks. Interestingly of the transcripts that change in level following
exposure to estradiol more transcripts go down than up, consistent
with estradiol being able to both repress and activate gene
expression (Table S4).
Gene ontology enrichment analysis highlighted numerous
signalling pathways in the molecular functions (Fig. S3)
including protein tyrosine kinase activity, ion channel activity,
GTPase regulator activity and glutamate receptor activity.
Consistent with these molecular functions, cellular response to
stimulus, regulation of signal transduction and glutamate receptor
signalling were highly enriched in the biological processes. The
enriched cellular components were consistent with the previously
described role in neuronal development (Yang et al., 2000; Nur-E-
Kamal et al., 2007; Tiwari et al., 2012; Capranico et al., 1992; Lyu
and Wang, 2003; King et al., 2013; Sano et al., 2008; Nevin et al.,
2011). Enriched KEGG pathways included multiple signalling
pathways including the ErbB signalling pathway and calcium
signalling. Since TOP2B plays a role in neural development we
looked for overlaps between our gene lists and those genes
implicated in the development of autism and schizophrenia, the
overlaps are shown in Fig. 4 and Table S1.One gene that is linked to
both autism and schizophrenia with an associated TOP2B peak is
the calcium channel protein CACNA1C (Bhat et al., 2012; Giusti-
Rodríguez and Sullivan, 2013).
Axon guidance was a significantly enriched KEGG pathway. The
top2b knockout mouse has an innervation problem, failing to
develop the dendrities between the nerve and the muscle cell at the
neuromuscular junction, indicative of an axon guidance error.
Notably the zebrafish mutant notorious (noto) lacks functional
top2b and displays neurite targeting defects in the retinal ganglion.
Specific heparin sulphate structures are involved in axon guidance
of retinal ganglion cells (Irie et al., 2002; Merry and Wilson, 2002).
Notably, the KEGG pathway for glycosaminoglycan biosynthesis
−heparan sulphate/heparin pathway is enriched in our data set
which suggests the possibility that topoisomerase regulation of
expression of enzymes that transfer sulphates onto heparan could
underlie the axon guidance errors seen in the zebrafish mutant noto
and in the top2b knockout mouse.
MATERIALS AND METHODS
Cell culture
MCF7 cells were cultured in Minimum Essential Medium Eagle (MEME)
(Sigma-Aldrich, M2279) supplemented with 10% (v/v) foetal bovine serum
(PAA, A15-151), 1% (v/v) penicillin and streptomycin (PAA, P11-010) and
1% (v/v) glutamine (200 mM) (GIBCO, 25030-032), 1% NEAA (Sigma-
Aldrich, M7145) in a 37°C incubator with 5% CO2. Estradiol (E2) was
dissolved in the above medium at a stock concentration of 20 µg/ml and for
E2 treatment was added to cells to a final concentration of 10 nM for 30 min.
Antibody purification
Rabbit polyclonal antisera 3535 and 30400 were raised in-house (Cowell
et al., 2012) to recombinant human TOP2B C-terminal domain, and the IgG
fraction purified on protein A sepharose beads. Western blots with these
antibodies are shown in Fig. S1.
Chromatin immunoprecipitation (ChIP)
ChIP was performed using the kits and the protocol from Millipore
(Magna ChIP A, 17-610/EZ-Magna ChIP A, 17-408). Briefly, MCF7 cells
were grown to ∼80% confluency and treated with 17β-estradiol (10 nM,
30 min) (Sigma-Aldrich). E2-treated and untreated (control) cells were
fixed with formaldehyde (1% (v/v), Sigma-Aldrich), neutralised with
glycine, washed with 1× PBS and trypsinised (0.05% trypsin in 0.53 mM
EDTA (Invitrogen, 25300-054). Cells were collected and lysed with
cell lysis buffer containing protease inhibitors, collected and resuspended
in nuclear lysis buffer containing protease inhibitors. Chromatin was
sonicated to between 500-1000 bp, 14×15 s cycles, and 5% was removed
as ‘input’. 3.6 µg anti-TOP2B (3535), 7 µg anti-TOP2B (30400), or 1 µg
anti-GFP (Santa Cruz Biotechnology, sc-8334) or 5 µg anti-AcH3
(Millipore, 06-599B) were added to protein A magnetic beads
(Invitrogen, 100.02D). Chromatin was diluted, incubated with the beads
and rotated for 4.5 h at 4°C. Immunoprecipitated protein-DNA complexes
were washed sequentially in Low Salt Buffer, High Salt Buffer, LiCl
Buffer and TE Buffer and then resuspended in ChIP Elution Buffer
+Proteinase K, rotated at 65°C for 2 h followed by incubation at 95°C for
10 min. DNAwas then purified using spin columns (Binding Reagent ‘A’,
Wash Buffer ‘B’, Elution reagent ‘C’).
Quantitative real time PCR (qPCR)
qPCR was performed using iQ SYBR green supermix (Bio-Rad,
10003253), primers including GAPDH control primers are shown in the
Table S1. qPCR parameters were −95°C for 5 min (1 cycle), 95°C for 25 s,
then 60°C for 25 s, then 72°C for 10 s (40 cycles), 72°C for 6 min (1 cycle).
Fig. 7. Configuration of several TOP2B peaks that coincide with gene
promoters. For each gene: from the top, ChIP-seq for ERα and RNA Pol II
(peaks shown as horizontal bars), position of any CpG island, position of
transcription factor motifs (from the list of overrepresented motifs listed in
Fig. S4), position of the TOP2B peak (horizontal bar), gene diagram (UCSC
transcripts) and hg18 genomic coordinates.
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Results were quantified as % input with GFP and AcH3% input values being
the negative and positive controls respectively.
ChIP Seq
Libraries were generated with chromatin immunoprecipitated from
MCF7 cells±E2 (10 nM for 30 min). Multiple immunoprecipitates were
pooled for each antibody (3535, 30400 and anti-GFP) to obtain between
400 and 800 ngDNA, at a concentration of 6-21 ng/µl for library preparation
for Illumina ChIP Sequencing on an Illumina Genome Analyser II. Each
library was sequenced 3 or 4 times for input libraries and for TOP2B
libraries. The data from the 3535 and 30400 libraries wasmerged to give >10
million uniquely aligned reads. Genome Alignment, the raw sequencing
reads were aligned to the human reference genome (hg18) using
BWA (v0.5.8c) (Li and Durbin, 2009) and alignment files were converted
to BED format using BEDTools (v2.12.0) (Quinlan and Hall, 2010).
BED files were used for peak calling by MACS (v1.4) (Zhang et al., 2008)
and SISSRs (Jothi et al., 2008) using INPUT controls as background.
Manual peak calling was carried out by visual inspection of aligned
sequence reads using Genome Studio software (2008.1 Framework),
employing input and GFP lanes as controls. Overlapping peak sets were
generated using bedtools intersect, and features coincident with consensus
peaks (gene neighbourhood, TSS, transcriptional markers), were also found
using bedtools intersect. Data is deposited in GEO, accession number
GSE66753.
Gene ontology and KEGG pathway enrichment
Gene ontology and KEGG pathway enrichment analysis was carried out
using GOstats (v 2.24.0) (Falcon and Gentleman, 2007) Bioconductor
package. Enrichment was then calculated by applying a hypergeometric test
and correcting for multiple tests as per Benjamini-Hochberg (Benjamini and
Hochberg, 1995). GO terms are reported as significant if they have a
corrected P<0.01.
Transcription factor motifs
Vertebrate transcription factor motifs were obtained in MEME format from
the Jaspar database (2014 release) (Mathelier et al., 2013). FIMO (v 4.9.1),
from the MEME suite (Bailey et al., 2009; Grant et al., 2011), was used to
find occurrences of motifs in the consensus peak sets and in the whole
reference genome. Binding site enrichment was then calculated by applying
a hypergeometric test and correcting for multiple tests as per Benjamini-
Hochberg (Benjamini and Hochberg, 1995). Motifs are reported as
significant if they have a corrected P<0.05. A distance measure for binary
attributes and Ward’s method was used for clustering of genes and
transcription factor motifs associated with TOP2B peaks. All heatmaps were
generated with the gplots v 2.12.1 BioConductor package.
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